H19 and breast cancer: H19 lncRNA is highly expressed in a variety of human cancers, including breast cancer, colorectal cancer, hepatocellular carcinoma, and gastric cancer [19–22], and its overexpression is often correlated with poor prognosis in cancer patients [23–25].